Kisunla for Alzheimer’s Now 40% Safer
July 10, 2025
Why Did Europe Finally Choose Lecanemab for Alzheimer’s?
Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart? (Video)
Source:
Related:
Ensuring Lecanemab Reaches Those Who Need It
June 5, 2025
Best Time to Stop Medicine for Dementia
May 29, 2025
Lecanemab’s Rare and Manageable Side Effects
May 23, 2025
How Many People Take Leqembi?
May 5, 2025
Email me when people comment
Login
0 Comments
Edited by:
P. Berger
Caring for dementias such as Alzheimer's among family and friends, Peter committed to help preserve the dignity of people affected by Alzheimer's. AlzheimersWeekly.com is the fruit of that commitment.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Dementia Books & Videos on Amazon:
More From Alzheimer's Weekly
Research
FDA-approved Rolipram Removes Alzheimer’s Tau and Improves Memory
Researchers found FDA-approved Rolipram promotes the removal of abnormal tau proteins, improving memory. This could be big news for tau-based brain diseases such as Alzheimer’s,
9 Comments
Prevention
Cataract Removal Linked to Reduced Dementia Risk
VIDEO + ARTICLE Eliminating sensory loss due to cataracts — by removing the cataracts — could reduce one’s risk of developing dementia, according to research
No Comments
Diagnosis
Why More People with Alzheimer’s Are Skinny
B.M.I. & ALZHEIMER’S: Studies have found an association between Alzheimer’s and the low BMI of thin people. The findings suggest this is not a causal
2 Comments
Clinical Trials
Alzheimer’s Agitation Reduced by Dextromethorphan-Quinidine Pill
MEDICATION & MOOD: Aggression and agitation are hard challenges in dementia. An important study may offer some simple answers.
4 Comments
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On